Steven R. Gerbsman, Principal of Gerbsman Partners and James McHugh, a member of Gerbsman Partners Board of Intellectual Capital, announced today their success in maximizing stakeholder value for a medical device company that focuses on flexible endoscopic technologies that enable surgical procedures through the body’s natural openings.
Gerbsman Partners facilitated the sale of the business and associated Intellectual Property and assets. Due to market conditions, the venture capital-backed company made the strategic decision to maximize the value of the business and Intellectual Property. Gerbsman Partners provided leadership to the company with:
- Crisis Management and technology experience in developing the strategic action plans for maximizing value of the business, Intellectual Property and assets;
- Proven domain expertise in maximizing the value of the business and Intellectual Property through a targeted and Date Certain M&A plan;
- The ability to "Manage the Process" among potential Acquirers, Lawyers, Creditors Management and Advisors;
- The proven ability to "Drive" toward successful closure for all parties at interest.
About Gerbsman Partners
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. In the past 60 months, Gerbsman Partners has been involved in maximizing value for 41 Technology and Life Science companies and their Intellectual Property and has restructured/terminated over $740 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception, Gerbsman Partners has been involved in over $2.2 billion of financings, restructurings and M&A transactions.
Gerbsman Partners has offices and strategic alliances in North America, Europe and Israel.